Претраживање
Приказ резултата 11-20 од 85
Undiagnosed Hyperglycaemia and Hypertension as Indicators of the Various Risk Factors of Future Cardiovascular Disease among Population of Serbian Students
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2018)
Background: A number of risk behaviours, such as smoking, overweight, excessive alcohol intake, insufficient physical activity, excessive and frequent intake of salt, reduced fruit and vegetable intake, increased fat intake, ...
Nitric oxide products are not associated with metabolic syndrome
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2019)
Background: Nitric oxide (NO) is oxidative stress biomarker which is regarded as one of the key determinants of energy metabolism and vascular tone. Considering the controversial reports on the association between nitric ...
Direct Estimation of Reference Intervals for Thyroid Parameters in the Republic of Srpska
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2017)
Background: The aim of this study was to determine the reference values for thyrotropin (TSH), thyroid hormones (total and free thyroxine, T4 and fT4; total and free triiodothyronine, T3 and fT3), thyroglobulin (Tg) and ...
Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2017)
Background: The aim of this study was to explore oxidative stress status, especially the enzyme myeloperoxidase in children with end-stage renal disease. Also, we investigated possible associations between the atherogenic ...
Influence of Promoter Polymorphisms of the Tnf-α (-308g/A) and IL-6 (-174g/C) Genes on Therapeutic Response to Etanercept in Rheumatoid Arthritis
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2015)
Background: The study was undertaken to assess the influence of functional -308G/A TNF-alpha (rs 1800629) and -174G/C IL-6 (rs1800795) promoter polymorphisms on the therapeutic response to etanercept, a TNF-alpha. blocker, ...
Introduction to Molecular genetic diagnostics
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2014)
Molecular genetic testing is part of modern medical practice. DNA tests are an essential part of diagnostics and genetic counseling in single gene diseases, while their application in polygenic disorders is still limited. ...
Guidelines for the use of tumor markers in breast cancer / Vodiči za primenu tumorskih markera kod karcinoma dojke
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2007)
The best-validated markers in breast cancer are all tissue based and include estrogen receptors (ER), progesteron receptors (PR), HER-2, urokinase plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1). ...
Relationship between cardiovascular risk score and traditional and nontraditional cardiometabolic parameters in obese adolescent girls
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2016)
Background: Since the cardiovascular (CV) risk score in the young population, children and adolescents, is underestimated, especially in developing countries such as Montenegro, where a strong interaction exists between ...
The clinical importance of biochemical bone markers in patients with alcoholic and viral liver cirrhosis
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2014)
Background: Metabolic bone disease in patients with chronic liver disease is called hepatic osteodystrophy and is primarily a sequel to osteopenia/osteoporosis, and rarely secondary to osteomalacia: The aim of this work ...
Recommedition for apllication and determination tumor markers of neuroendocrine system / Preporuke za primenu i odredivanje tumorskih markera kod neoplazmi neuroendokrinog sistema
(Društvo medicinskih biohemičara Srbije, Beograd i Versita, 2007)
Neuroendocrine tumors derive from neuroendocrine cells, which upon specific stimulation secrete stimulation secrete hormones regulating various bodily functions. We will discuss the group of neuroendocrine tumors which is ...